Home » Stocks » VERO

Venus Concept Inc. (VERO)

Stock Price: $2.32 USD -0.08 (-3.33%)
Updated Jan 21, 2021 4:00 PM EST - Market closed
After-hours: $2.28 -0.04 (-1.72%) Jan 21, 6:05 PM
Market Cap 98.72M
Revenue (ttm) 150.96M
Net Income (ttm) -90.22M
Shares Out 40.47M
EPS (ttm) 2.00
PE Ratio 1.16
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 21
Last Price $2.32
Previous Close $2.40
Change ($) -0.08
Change (%) -3.33%
Day's Open 2.37
Day's Range 2.22 - 2.37
Day's Volume 1,053,449
52-Week Range 1.67 - 8.20

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation
GlobeNewsWire - 1 week ago

TORONTO, Jan. 14, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today reported preliminary unaudi...

GlobeNewsWire - 2 weeks ago

TORONTO, Jan. 05, 2021 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management w...

GlobeNewsWire - 4 weeks ago

TORONTO, Dec. 22, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (Nasdaq: VERO), a global medical aesthetic technology leader, today announced the pricing of it...

GlobeNewsWire - 1 month ago

TORONTO, Dec. 21, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it intends t...

GlobeNewsWire - 1 month ago

New loan and debt exchange agreements significantly enhance balance sheet and financial condition by lowering overall cost of borrowing, reducing annual interest expense and improving future c...

GlobeNewsWire - 1 month ago

TORONTO, Dec. 01, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that the Company ...

Seeking Alpha - 2 months ago

Venus Concept, Inc. (VERO) CEO Domenic Serafino on Q3 2020 Results - Earnings Call Transcript

Zacks Investment Research - 2 months ago

Venus Concept (VERO) delivered earnings and revenue surprises of 25.00% and -21.84%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the st...

Benzinga - 2 months ago

Shares of Venus Concept (NASDAQ:VERO) moved higher by 3.9% in pre-market trading after the company reported Q3 results. Quarterly Results Earnings per share rose 82.35% over the past year to (...

GlobeNewsWire - 2 months ago

TORONTO, Nov. 16, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for t...

GlobeNewsWire - 2 months ago

TORONTO, Nov. 03, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that management w...

GlobeNewsWire - 3 months ago

TORONTO, Oct. 15, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced that third quarter of f...

Seeking Alpha - 5 months ago

Venus Concept, Inc. (VERO) CEO Domenic Serafino on Q2 2020 Results - Earnings Call Transcript

Zacks Investment Research - 5 months ago

Venus Concept (VERO) delivered earnings and revenue surprises of -8.33% and 2.70%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

GlobeNewsWire - 5 months ago

TORONTO, Aug. 13, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for...

Zacks Investment Research - 5 months ago

Venus Concept (VERO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

GlobeNewsWire - 6 months ago

TORONTO, July 16, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today reported preliminary reve...

GlobeNewsWire - 6 months ago

Venus Viva MD is a new skin rejuvenation solution with differentiated features that allow clinicians in the traditional medical aesthetics community to treat a wider range of skin conditions V...

GlobeNewsWire - 6 months ago

TORONTO, June 26, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced today that the Compan...

Zacks Investment Research - 6 months ago

Forget undervalued stocks, play these top-ranked stocks with rising P/E.

Other stocks mentioned: JAGX, SNCR, STNG
GlobeNewsWire - 7 months ago

TORONTO, June 16, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has ent...

GlobeNewsWire - 7 months ago

Venus Epileve is a new, cost-effective, laser hair removal solution designed for customers in the aesthetics market Venus Epileve is a new, cost-effective, laser hair removal solution designed...

Seeking Alpha - 8 months ago

Venus Concept Inc. (VERO) CEO Domenic Serafino on Q2 2020 Results - Earnings Call Transcript

Zacks Investment Research - 8 months ago

Venus Concept (VERO) delivered earnings and revenue surprises of -14.12% and -13.54%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

GlobeNewsWire - 8 months ago

TORONTO, May 14, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, announced financial results for ...

Zacks Investment Research - 8 months ago

Venus Concept (VERO) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Seeking Alpha - 9 months ago

Venus Concept Inc. (VERO) CEO Domenic Serafino on Q4 2019 Results - Earnings Call Transcript

GlobeNewsWire - 10 months ago

TORONTO, March 18, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it entere...

GlobeNewsWire - 10 months ago

Chad A. Zaring, Appointed Chief Commercial Officer Chad A. Zaring, Appointed Chief Commercial Officer

GlobeNewsWire - 11 months ago

TORONTO, Feb. 14, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has rec...

GlobeNewsWire - 1 year ago

TORONTO, Jan. 13, 2020 (GLOBE NEWSWIRE) -- Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced preliminary una...

Other stocks mentioned: HAIR

About VERO

Venus Concept operates as a medical aesthetic technology company worldwide. Its product portfolio includes aesthetic device platforms, including Venus Versa, a multi-treatment platform to address the aesthetic procedures without surgery or downtime; Venus Legacy, an advanced device that resolves challenging face and body aesthetic needs; Venus Velocity, a diode laser for hair removal; Venus Fiore, which addresses internal vaginal health restoration, labia skin tightening, and mons pubis reduction; Venus Viva, a customizable skin resurfacing dev... [Read more...]

Industry
Medical Devices
CEO
Domenic Serafino
Employees
525
Stock Exchange
NASDAQ
Ticker Symbol
VERO
Full Company Profile

Financial Performance

In 2019, Venus Concept's revenue was $110.41 million, an increase of 7.59% compared to the previous year's $102.61 million. Losses were -$40.62 million, 171.5% more than in 2018.

Financial Statements

Analyst Forecasts

According to 5 analysts, the average rating for Venus Concept stock is "Buy." The 12-month stock price forecast is 5.50, which is an increase of 137.07% from the latest price.

Price Target
$5.50
(137.07% upside)
Analyst Consensus: Buy